Typical exogenous ligands for PPARα and PPARγ are bezafibrate and pioglitazone, respectively, which are used as PPAR agonists to treat hyperlipidemia and insulin resistance, respectively. The gene discussed is PPARA; the disease is hyperlipidemia.